Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tirzepatide should be administered subcutaneously in the abdomen, thigh, or upper arm, with site rotation to prevent lipohypertrophy or lipoatrophy that can impair absorption
Tirzepatide is a prescription medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (marketed as Zepbound)
A., Hikim, A
A publication in the New England Journal of Medicine in 2021 demonstrated that Vafseos safety was not significantly worse than darbepoetin alfa regarding the change in mean hemoglobin levels and that it had a similar safety profile as darbepoetin alfa
